Unmet Needs in Treating Relapsed/Refractory FL
Laurie Sehn, MD, and Bijal Shah, MD, discuss remaining unmet needs for patients with relapsed/refractory FL.
Source: onclive.com
📰 Pod 24 News
Pod 24 News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pod 24. Real-time updates on events, politics, business and more.
Tazemetostat as Third-line and Beyond Therapy for FL
Peter Martin, MD, discusses recent data on tazemetostat, an EZH2 inhibitor, as third-line and beyond therapy for FL.
Peter Martin Recent Updates Follicular Lymphoma Mantle Cell Lymphoma Beyond Therapy Third Line And Beyond
Source: onclive.com
CAR T-cells as Third-line and Beyond Therapy for FL
Bijal Shah, MD, discusses recent data on CAR T-cell therapy as third-line and beyond treatment for FL.
Source: onclive.com